AU2006226381B2 - Use of macrolides for treating intestinal inflammation - Google Patents
Use of macrolides for treating intestinal inflammation Download PDFInfo
- Publication number
- AU2006226381B2 AU2006226381B2 AU2006226381A AU2006226381A AU2006226381B2 AU 2006226381 B2 AU2006226381 B2 AU 2006226381B2 AU 2006226381 A AU2006226381 A AU 2006226381A AU 2006226381 A AU2006226381 A AU 2006226381A AU 2006226381 B2 AU2006226381 B2 AU 2006226381B2
- Authority
- AU
- Australia
- Prior art keywords
- formula
- compound
- pharmaceutically acceptable
- acceptable salt
- inflammatory bowel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05102244 | 2005-03-21 | ||
| EP05102244.0 | 2005-03-21 | ||
| PCT/EP2006/060709 WO2006100195A1 (en) | 2005-03-21 | 2006-03-14 | Use of macrolides for treating intestinal inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2006226381A1 AU2006226381A1 (en) | 2006-09-28 |
| AU2006226381B2 true AU2006226381B2 (en) | 2011-09-08 |
Family
ID=36649815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006226381A Ceased AU2006226381B2 (en) | 2005-03-21 | 2006-03-14 | Use of macrolides for treating intestinal inflammation |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080249034A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1868619A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008533186A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101212980A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006226381B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0614009A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2601640C (cg-RX-API-DMAC7.html) |
| EA (1) | EA012309B1 (cg-RX-API-DMAC7.html) |
| IT (1) | ITMI20060460A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007011544A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006100195A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200708423B (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1907406T3 (pl) | 2005-07-06 | 2010-10-29 | Zambon Spa | Krystaliczne postacie związków makrolidowych wykazujące aktywność przeciwzapalną |
| WO2008065636A2 (en) * | 2006-12-01 | 2008-06-05 | University College York - National University Of Ireland, Cork | Treatment of disease by modulating cf5 protein |
| CN117750889A (zh) * | 2021-02-26 | 2024-03-22 | 潘思瑞公司 | 稳定的初乳组合物 |
| CN113209084A (zh) * | 2021-05-18 | 2021-08-06 | 南开大学 | 化合物cp0119在制备用于治疗炎性肠病的药物中的应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5712253A (en) * | 1996-06-18 | 1998-01-27 | Abbott Laboratories | Macrocyclic 13-membered ring derivatives of erythromycins A and B |
| WO2004013153A2 (en) * | 2002-08-01 | 2004-02-12 | Zambon Group S.P.A. | Macrolide compounds endowed with antiinflammatory activity |
| US20040198677A1 (en) * | 2001-01-09 | 2004-10-07 | Mlanden Mercep | Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2089219C1 (ru) * | 1994-02-22 | 1997-09-10 | Александра Леонидовна Бурмистрова | Способ лечения неспецифического язвенного колита |
| US6551632B2 (en) * | 1997-04-01 | 2003-04-22 | Thomas Julius Borody | Methods and compositions for treating inflammatory bowel disease |
| IT1306205B1 (it) * | 1999-01-15 | 2001-05-30 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria. |
| ITMI20040124A1 (it) * | 2004-01-29 | 2004-04-29 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria |
-
2005
- 2005-03-14 US US11/908,550 patent/US20080249034A1/en not_active Abandoned
-
2006
- 2006-03-14 EP EP06725052A patent/EP1868619A1/en not_active Withdrawn
- 2006-03-14 EA EA200702036A patent/EA012309B1/ru not_active IP Right Cessation
- 2006-03-14 MX MX2007011544A patent/MX2007011544A/es not_active Application Discontinuation
- 2006-03-14 AU AU2006226381A patent/AU2006226381B2/en not_active Ceased
- 2006-03-14 JP JP2008502380A patent/JP2008533186A/ja active Pending
- 2006-03-14 WO PCT/EP2006/060709 patent/WO2006100195A1/en not_active Ceased
- 2006-03-14 BR BRPI0614009-2A patent/BRPI0614009A2/pt not_active IP Right Cessation
- 2006-03-14 CA CA2601640A patent/CA2601640C/en not_active Expired - Fee Related
- 2006-03-14 CN CNA2006800126183A patent/CN101212980A/zh active Pending
- 2006-03-15 IT IT000460A patent/ITMI20060460A1/it unknown
-
2007
- 2007-10-02 ZA ZA200708423A patent/ZA200708423B/xx unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5712253A (en) * | 1996-06-18 | 1998-01-27 | Abbott Laboratories | Macrocyclic 13-membered ring derivatives of erythromycins A and B |
| US20040198677A1 (en) * | 2001-01-09 | 2004-10-07 | Mlanden Mercep | Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| WO2004013153A2 (en) * | 2002-08-01 | 2004-02-12 | Zambon Group S.P.A. | Macrolide compounds endowed with antiinflammatory activity |
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI20060460A1 (it) | 2006-09-22 |
| BRPI0614009A2 (pt) | 2011-03-01 |
| EP1868619A1 (en) | 2007-12-26 |
| WO2006100195A1 (en) | 2006-09-28 |
| MX2007011544A (es) | 2008-03-11 |
| EA012309B1 (ru) | 2009-08-28 |
| AU2006226381A1 (en) | 2006-09-28 |
| JP2008533186A (ja) | 2008-08-21 |
| US20080249034A1 (en) | 2008-10-09 |
| CA2601640C (en) | 2013-10-22 |
| EA200702036A1 (ru) | 2008-02-28 |
| CN101212980A (zh) | 2008-07-02 |
| ZA200708423B (en) | 2009-03-25 |
| CA2601640A1 (en) | 2006-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2470185B1 (en) | Pharmaceutical compositions for treating IBD | |
| EP1031350A1 (en) | Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain | |
| PT92821B (pt) | Processo para a preparacao composicoes farmaceuticas para o combate de doencas do tipo psoriase, bem como doencas inflamatorias, incorporando azelastina como substancia activa | |
| EP1017403B1 (en) | Use of zinc hyaluronate against peptic ulcer | |
| JP2003517443A (ja) | 炎症性腸疾患を治療するための方法および組成物 | |
| AU2007341218A1 (en) | Isosorbide mononitrate derivatives for the treatment of intestinal disorders | |
| CA2601640C (en) | Use of macrolides for treating intestinal inflammation | |
| EP0811376B1 (en) | Use of alkanoyl L-carnitines for the manufacture of a medicament for the treatment of inflammatory bowel diseases | |
| WO2016121147A1 (ja) | 注腸剤 | |
| ES2358564T3 (es) | Derivados de carbonilamino útiles para el tratamiento de una enfermedad inflamatoria intestinal. | |
| CN105079012B (zh) | 天麻素在制备防治溃疡性结肠炎的药物或食品中的应用 | |
| CN104983728B (zh) | 金合欢素在制备防治溃疡性结肠炎的药物或食品中的应用 | |
| JP2018108993A (ja) | 注腸剤 | |
| CN117379423A (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| AU2008257319B2 (en) | Use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas | |
| CN105147661A (zh) | 升麻素在制备防治溃疡性结肠炎的药物或食品中的应用 | |
| RU2057530C1 (ru) | Способ лечения язвы желудка в эксперименте | |
| RU2294204C1 (ru) | Способ лечения язвенной болезни желудка и двенадцатиперстной кишки | |
| ES2357245T3 (es) | Inhibidor de los pólipos intestinales. | |
| US20080076827A1 (en) | Treatment of Inflammatory Bowel Disease | |
| CN114306299A (zh) | 贝利司他在制备缓解和/或治疗缺血性脑卒中药物中的应用 | |
| AU2003297216A1 (en) | Dehydroepiandrosterone (dhea) congeners for prevention and/or treatment of ulcers | |
| Turner | Oestrogen. Sex hormone: see OESTRA | |
| Turner | alkaloids: see MORPHINE. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |